Related content

Editorial Commentary : Balancing Disease Eradication With the Emergence of Multidrug-Resistant HIV in Test-and-Treat Policies

By Jena Anupam B.  

Clinical Infectious Diseases, Vol. 56, Iss. 12, 2013-06 ,pp. : 1797-1799

Oxford University Press

Access to resources Recommend Favorite

Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study

By Eschenauer Gregory A.   Carver Peggy L.   Lin Shu-Wen   Klinker Kenneth P.   Chen Yee-Chun   Potoski Brian A.   Shields Ryan K.   Clancy Cornelius J.   Nguyen Minh-Hong   Lam Simon W.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 4, 2013-04 ,pp. : 922-926

Oxford University Press

Access to resources Recommend Favorite

Effective multidrug-resistant tuberculosis treatment

By Nierengarten M.B.  

The Lancet Infectious Diseases, Vol. 3, Iss. 3, 2003-03 ,pp. : 118-118

Elsevier

Access to resources Recommend Favorite

Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis

By Conway S.P.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 4, 2003-01 ,pp. : 321-332

Adis International

Access to resources Recommend Favorite

Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans

By Calabrese Elena C.   Castellano Sabrina   Santoriello Marisabella   Sgherri Cristina   Quartacci Mike F.   Calucci Lucia   Warrilow Andrew G. S.   Lamb David C.   Kelly Steven L.   Milite Ciro   Granata Ilaria   Sbardella Gianluca   Stefancich Giorgio   Maresca Bruno   Porta Amalia  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 5, 2013-05 ,pp. : 1111-1119

Oxford University Press

Access to resources Recommend Favorite